ASAHI INTECC CO., LTD. Is the world leader in the production of coronary conductors and devices for overcoming chronic occlusions. The company was founded in 1972, under the name of Asahi Mini Rope Co., Ltd. in Japan, as a manufacturer of ultra-thin steel wire braiding and conductor materials. Since 1988 the company is called ASAHI INTECC CO., LTD.
Goodman Co., Ltd. - A private Japanese company, established in 1975. Started its activities as an importer and distributor (since 1981) of medical equipment and medical products. However, in 1984 she organized her own production of medical devices for minimally invasive intravascular operations.
Acist Medical System is the world leader in the production of contrast systems for angiography. It was the company Acist Medical Systems that introduced the concept of "variable flow" into the process of X-ray endovascular interventions, which allowed replacing the manual introduction of contrast in coronary angiography, using an automatic injector. This made coronary angiography much safer and more effective, allowed to reduce the dose of contrast administered and, as a consequence, reduced the likelihood of development of contrast-induced nephropathy.
Abiomed is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. CEO, Chairman, and President Michael R. Minogue has focused the company’s efforts on developing ground-breaking technologies designed to improve the patient outcomes focused on native heart recovery. Founded in 1981 for the purpose of developing the world’s first artificial heart, Abiomed has remained dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.
Straub Medical AG is the world leader in the manufacture of systems for mechanical intravascular thrombectomy. The idea of mechanical intravascular thrombectomy was born in the early 90s. In 1995, a patent of the Rotarex system was obtained. In 1999, the system received CE Mark for the Rotarex system. In 2004-2005, the Aspirex system was patented and received the CE Mark system.
The company Stentys S.A. was founded in 2006 for the development and production of coronary stents with the property of adaptive apposition - Self-Aporing ® Stent System
These stents are able to change the diameter after installation without the need for balloon post-dilatation, which facilitates the correct choice of the stent size for myocardial infarction and for certain anatomical characteristics of the affected area - the left coronary artery trunk, bifurcations, ectatic artery transformation, and other recalibration options.
Founded in 1987 in the United States of America and rightfully considered a world leader, Merit Medical Systems Inc. produces various devices that are used in diagnostic and intervention interventions on coronary and peripheral vessels, as well as in other non-vascular diseases.